Navigation Links
Astellas US Appoints Senior Vice President, Chief Communications Officer
Date:10/30/2013

NORTHBROOK, Ill., Oct. 30, 2013 /PRNewswire/ -- Astellas US LLC ("Astellas"), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, welcomes Jeffrey Winton as senior vice president, chief communications officer. Winton will report to Masao Yoshida, CEO, Astellas.  In this newly created position, Winton will have responsibility for corporate brand and reputation management in the Americas.

(Photo: http://photos.prnewswire.com/prnh/20131030/CG07002)

"I am pleased to add Jeff to our senior management team at Astellas," said Yoshida. "Jeff brings with him the broad industry expertise and experience we are looking for to help propel the Astellas brand in the Americas."

Winton has more than 30 years of communications experience in the pharmaceutical industry and has successfully led large, global teams. Most recently, Winton was the Vice President/Head, Global Communications and member of Global Corporate Affairs Leadership Team at Eli Lilly and Company.  In this role, his responsibilities included CEO/executive communications, corporate/financial communications, government and policy communications, business communications and employee engagement. Prior to his tenure at Eli Lilly, Winton held senior communications roles at major global pharmaceutical companies such as Schering-Plough and Pharmacia. Winton holds a Bachelor of Science degree in life sciences from Cornell University in Ithaca, New York.

About Astellas

Astellas US LLC, located in Northbrook, Illinois, is an affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us.


'/>"/>
SOURCE Astellas US, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Astellas Employees to Change Tomorrow through Annual Day of Service
2. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
3. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
4. Astellas Appoints New Senior Vice President of Global Oncology Development
5. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
6. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the AT&T National
7. Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
8. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the FedEx St. Jude Classic
9. Amgen And Astellas Announce Japan Alliance
10. Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen
11. Astellas Joins the National Pharmaceutical Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... and EDMONTON, Alberta , ... scientists and the University of Alberta in ... data in Nature,s partner journal, Schizophrenia 1 , ... predict instances of schizophrenia with 74% accuracy. This ... severity of specific symptoms in schizophrenia patients with ...
(Date:7/21/2017)... Did you know that PhRMA member companies invested $65.5 billion in ... brand medicines, generics and the supply chain account for 14 percent ... of this (7 percent)? Or that the United States ... investments in high-growth biopharmaceutical startups? ... The biopharmaceutical industry accounts ...
(Date:7/17/2017)... Fla. , July 17, 2017  MedX Holdings, ... branded medical testing, strengthening and rehabilitation equipment, today announced ... Machine Program. MedX is considered the gold standard for ... leader in specialized medical strengthening equipment. ... a lease with the physician or practice who prescribe ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... ... effectively destroyed the construction site and threatened numerous homes and businesses nearby, causing ... article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire Protection Group, Inc. ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... Axiad ... organizations, today announced it has partnered with WALLIX to expand its solution ... 800-171 . , There are a number of ways to address the authentication requirements ...
(Date:7/24/2017)... ... 24, 2017 , ... Puregraft, the global leader in the ... United States Patent Number 9,695,398 (the '398 patent) and South Korean Patent Number ... '324 patents cover methods and systems for optimizing fat grafts for current and ...
(Date:7/24/2017)... ... 2017 , ... A new report released today by FusionHealth, ... health care at scale, indicates record-breaking adherence results for the company’s obstructive sleep ... pressure (PAP) therapy, the most widely utilized treatment for OSA, typically range between ...
(Date:7/24/2017)... ... July 24, 2017 , ... Committed to eliminating ... enrolled over 100,000 children in their treatment program. Clubfoot is a pervasive problem ... where treatment is limited or non-existent. Without intervention, these children are destined to ...
Breaking Medicine News(10 mins):